6 days ago
Dr Reddy's kicks off India big pharma earnings with profit miss
July 23 (Reuters) - Indian generic drugs maker Dr Reddy's Laboratories ( opens new tab missed quarterly profit expectations on Wednesday, as it struggled with pricing pressure on drugs and stiff competition in its key North America market.
The company's consolidated net profit increased to 14.18 billion rupees ($164.2 million) in the quarter ended June 30, below analysts' estimate of 14.94 billion rupees, as per data compiled by LSEG.
($1 = 86.3800 Indian rupees)